CVE-2026-77930EvoScientist 0.1.0 before 0.2.5 Human Approval Bypass via Async Sub-Agents
Updated under an hour ago ()
Does this affect you?
It affects EvoScientist. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.56%, higher than 46% of scored CVEs.
Do this next
Free account, 1 product
EvoScientist 0.1.0 before 0.2.5 contains an approval bypass vulnerability that allows attackers to run host shell commands by delegating them to async sub-agents lacking an interrupt_on gate. Attackers can plant instructions in ingested content such as fetched web pages, so the agent calls start_async_task and runs commands with user privileges and environment secrets.
- CVSS
- 9.8 CRITICAL (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-862
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.56% (percentile 46)
- Assigned by
- VulnCheck
- NVD analysis
- Deferred
- Record last updated
- Oct 22, 2026
- First seen by InfoSec Signals
- Oct 19, 2026
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.